Xuantai Pharmaceuticals: Net profit in the first half of 2025 was 45.5857 million yuan, a year-on-year decrease of 15.82%.

Xuantai Pharmaceuticals announced that in the first half of 2025, the operating income was 220 million yuan, a year-on-year increase of 0.74%. The net profit was 45.5857 million yuan, a year-on-year decrease of 15.82%. The company plans to distribute a cash dividend of 0.25 yuan per 10 shares to all shareholders, with a total cash dividend of 11.2251 million yuan, accounting for 24.62% of the net profit attributable to the parent company's shareholders from January to June 2025.